Saturday, October 31, 2026

Back to today

From X

@convequity 3 clicks

Convequity on X

$CRWV 5-year CDS hit a record ~1,195bp on 15 Oct and the whole neocloud group sold off with it. Our ABBX tracker suggests the market is pricing contagion into the wrong names. The balance sheet first. At 30 June CoreWeave had $35.6B of debt against $5.5B of cash, and its ~$33B market cap now sits below its debt. $4.4B falls due in the rest of 2026 and $6.2B in 2027, mostly loan amortisation; no bond matures before 2030. Its 9.625% notes sold at par in June now yield ~14.9%. Add $16.3B of lease liabilities and $35.5B of leases not yet started. CoreWeave's Q2 operating cash flow: Net loss: −$0.63B + Depreciation & amortisation: +$1.39B + Stock-based comp: +$0.17B + Other non-cash items: +$0.28B − Working capital (payables, receivables, prepaids): −$1.32B + Customer prepayments: +$0.79B = Operating cash flow: $0.68B The core business makes cash, but working capital ate it. Without the prepayments OCF was −$0.11B. That OCF is already after ~$0.44B of cash interest, equal to 65% of it, and capex ran 9.5x OCF. Funding is where the group splits. CoreWeave builds with borrowed money: GPU-backed loans, 8.5–9.75% bonds and vendor credit, with ~$9.8B of H1 equipment supplier-financed outside the cash-flow statement. Prepayments covered 12% of its Q2 capex. $NBIS builds with convertibles (~$9B this year) and prepayments that covered 21% of Q2 capex; at 30 June it held $8.5B of debt against $8.0B of cash. $IREN builds with equity, a $3B 1% convertible and prepayments that covered 87% of its latest quarter's capex; net debt is ~$1.7B and cash interest equalled ~1% of OCF. The exposure that matters is its landlords. CoreWeave is ~77% of $CORZ revenue, the tenant at Galaxy's Helios campus and leases 400MW from $APLD. Yet since 2 Oct Core Scientific is down 17%, while Microsoft-anchored IREN is down 34% and Nebius 30%. Our view: the risk is CoreWeave's debt-funded build, not the neocloud model. If CoreWeave stumbles, the hit lands on the landlords that depend on its rent. Nebius and IREN share the model, not the funding.

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

TSOH Weekly Roundup (10/30/2026)

Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

SAP · long

Sap Se

SAP shares are down 45% since February 2025 as AI disruption fears create a long thesis on its risk-reward.

INTC Q3 FY12/26 Earnings Review

Intel's Q3 revenue rose 21% to $16.5 billion, led by 78% data-center and AI growth, but Q4 guidance of $15.5 billion trailed consensus.

Twilio CEO: ‘Buy the dip!’

Twilio CEO Khozema Shipchandler urged investors to “buy the dip” after earnings sent the software maker’s shares down 17% after hours.

CoStar: 3Q26 Business Recap

CoStar’s 3Q26 revenue growth slowed to 14% as bookings fell to $37 million, while cost cuts lifted EBIT margin to 8.8%.

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.